ライフサイエンスコーパス: Gram-negative bacteremia

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ne expression are associated with subsequent Gram-negative bacteremia.

2 use of antibiotic treatment in patients with gram-negative bacteremia.

3 ed on blood culture pellets in patients with gram-negative bacteremia.

4 alent complex with GBOMP may protect against gram-negative bacteremia.

5 c decision making in pediatric patients with Gram-negative bacteremia.

6 ous complications were rare and consisted of gram-negative bacteremia (1.6%), gram-positive bacteremi

7 Gram-negative bacteremia after trauma is, in part, conse

8 Mice receiving 11 doses of morphine showed gram-negative bacteremia and bacterial growth in samples

9 -positive bacteremia, from 5.3% to 41.9% for gram-negative bacteremia, and from 0.6% to 26.1% for fun

10 terobacteriaceae isolates from patients with gram-negative bacteremia at a 1,250-bed teaching hospita

11 am-positive bacteremia than in patients with gram-negative bacteremia, but this difference was not st

12 t on the clinical management of 35.1% of all gram-negative bacteremia cases, demonstrating a greater

13 be enriched in a cohort of 180 patients with gram-negative bacteremia, compared with 229 healthy cont

14 ociated with increased hospital mortality in Gram-negative bacteremia complicated by severe sepsis or

15 on was compared between the subjects in whom Gram-negative bacteremia developed and those in whom it

16 r injury in 10 subjects in whom subsequently Gram-negative bacteremia developed matched to 26 subject

17 Gram-negative bacteremia (GNB) is a major cause of illne

18 Among 202 episodes of gram-negative bacteremia, Gram stain reporting had an im

19 g pediatric patients (aged </=18 years) with gram-negative bacteremia hospitalized at the Johns Hopki

20 to multiple organ failure in human cases of gram-negative bacteremia; however, little is known regar

21 We retrospectively reviewed cases of Gram-negative bacteremia in hospitalized patients over a

22 The use of beta-lactam monotherapy for gram-negative bacteremia in pediatric patients reduces s

23 m and an aminoglycoside for the treatment of gram-negative bacteremia is commonly prescribed in pedia

24 Currently, the management of gram-negative bacteremia is determined by clinical judgm

25 Gram-negative bacteremia is highly fatal, and hospitaliz

26 appears to be differentially regulated after gram-negative bacteremia; LPS cleared by liver and lung

27 xpression associated with the development of Gram-negative bacteremia, reflecting suppression of both

28 the detrimental inflammatory response during Gram-negative bacteremia remain poorly defined.

29 n-regulation of adaptive immune genes in the Gram-negative bacteremia subjects.

30 reflecting suppression of innate immunity in Gram-negative bacteremia subjects.

31 s retrospective study included patients with gram-negative bacteremia treated with intravenous colist

32 We observed that Gram-negative bacteremia was an independent risk factor

33 The incidence of Gram-negative bacteremia was significantly reduced in th

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。